Schedule of Error Corrections and Prior Period Adjustments | 12. Immaterial Restatement of Prior Period Financial Statements As discussed in Note 1, the Company made corrections to the consolidated financial statements for periods ended December 31, 2022, January 1, 2022, and the quarterly periods of 2023. A summary of the corrections related to prior periods presented are as follows (tables may not foot or cross foot due to rounding): Condensed Consolidated Statement of Operations July 15, 2023 Twelve Weeks Ended Twenty-Eight Weeks Ended As Adjustments As As Adjustments As Cost of sales $ 1,537,997 $ 7,614 $ 1,545,611 $ 3,484,927 $ 16,350 $ 3,501,277 Gross profit 1,148,069 (7,614) 1,140,455 2,618,732 (16,350) 2,602,382 Selling, general and administrative expenses 1,013,701 794 1,014,495 2,394,365 (15,881) 2,378,484 Operating income 134,368 (8,408) 125,960 224,367 (469) 223,898 Income before provision for income taxes 115,183 (8,408) 106,775 174,789 (469) 174,320 Provision for income taxes 29,821 (1,623) 28,198 46,776 644 47,420 Net income $ 85,362 $ (6,785) $ 78,577 $ 128,013 $ (1,113) $ 126,900 Basic earnings per share $ 1.44 $ (0.12) $ 1.32 $ 2.16 $ (0.02) $ 2.14 Diluted earnings per common share $ 1.43 $ (0.11) $ 1.32 $ 2.15 $ (0.02) $ 2.13 Condensed Consolidated Statement of Comprehensive Income July 15, 2023 Twelve Weeks Ended Twenty-Eight Weeks Ended As Adjustments As As Adjustments As Net income $ 85,362 $ (6,785) $ 78,577 $ 128,013 $ (1,113) $ 126,900 Currency translation adjustments 7,569 (307) 7,262 8,160 (331) 7,829 Total other comprehensive loss 7,531 (307) 7,224 8,319 (331) 7,988 Comprehensive income $ 92,893 $ (7,092) $ 85,801 $ 136,332 $ (1,444) $ 134,888 Condensed Consolidated Statements of Changes in Stockholders’ Equity Twelve Weeks Ended July 15, 2023 Accumulated Other Retained Total Stockholders' Equity Twelve Weeks Ended As Previously Reported Balance at April 22, 2023 $ (44,355) $ 4,697,697 $ 2,636,161 Net income — 85,362 85,362 Total other comprehensive income 7,531 — 7,531 Balance at July 15, 2023 $ (36,824) $ 4,767,168 $ 2,723,187 Adjustments Balance at April 22, 2023 $ 424 $ (73,865) $ (73,441) Net income — (6,785) (6,785) Total other comprehensive income (307) — (307) Balance at July 15, 2023 $ 117 $ (80,650) $ (80,533) As Corrected Balance at April 22, 2023 $ (43,931) $ 4,623,832 $ 2,562,720 Net income — 78,577 78,577 Total other comprehensive income 7,224 — 7,224 Balance at July 15, 2023 $ (36,707) $ 4,686,518 $ 2,642,654 Condensed Consolidated Statements of Changes in Stockholders’ Equity Twenty-Eight Weeks Ended July 15, 2023 Accumulated Other Retained Total Stockholders' Equity Twenty-Eight Weeks Ended As Previously Reported Balance at December 31, 2022 $ (45,143) $ 4,744,624 $ 2,678,281 Net income — 128,013 128,013 Total other comprehensive income 8,319 — 8,319 Balance at July 15, 2023 $ (36,824) $ 4,767,168 $ 2,723,187 Adjustments Balance at December 31, 2022 $ 448 $ (79,537) $ (79,089) Net income — (1,113) (1,113) Total other comprehensive income (331) — (331) Balance at July 15, 2023 $ 117 $ (80,650) $ (80,533) As Corrected Balance at December 31, 2022 $ (44,695) $ 4,665,087 $ 2,599,192 Net income — 126,900 126,900 Total other comprehensive income 7,988 — 7,988 Balance at July 15, 2023 $ (36,707) $ 4,686,518 $ 2,642,654 Condensed Consolidated Statement of Cash Flows Twenty-Eight Weeks Ended July 15, 2023 As Previously Reported Adjustments As Corrected Net income $ 128,013 $ (1,113) $ 126,900 Provision for deferred income taxes 16,249 5,248 21,497 Other, net 1,170 458 1,628 Net change in: Receivables, net (93,539) (3,483) (97,022) Inventories, net (145,148) (3,770) (148,918) Accounts payable (346,808) 27,023 (319,785) Accrued expenses 120,888 (2,107) 118,781 Other assets and liabilities, net (36,008) (24,828) (60,836) Net cash used in operating activities (164,559) (2,572) (167,131) Other, net (1) (4,073) (458) (4,531) Net cash provided by financing activities 314,403 (458) 313,945 Effect of exchange rate changes on cash 1,280 (331) 949 Net increase in cash and cash equivalents 7,782 (3,361) 4,421 Cash and cash equivalents, beginning of period 269,282 1,523 270,805 Cash and cash equivalents, end of period $ 277,064 $ (1,838) $ 275,226 (1) |